Industry: Medical Devices & Consumables
Published Date: 2025-03-10
Pages: 137 Pages
Report ld: 4616971
Request Sample
Customized Report
Extracellular Matrix (ECM) Market Size(US$)

CAGR 2025-2031
7.7%
Market Size,2031
USD 66.1
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Extracellular Matrix (ECM) was estimated to be worth US$ 39.6 million in 2024 and is forecast to a readjusted size of US$ 66.1 million by 2031 with a CAGR of 7.7% during the forecast period 2025-2031.
The extracellular matrix (ECM) is a complex network of proteins and carbohydrates that provides structural and biochemical support to the surrounding cells in tissues. It is composed of various molecules, including collagen, elastin, glycoproteins, and proteoglycans, which create a scaffold that maintains tissue integrity and regulates cellular behaviors such as adhesion, migration, proliferation, and differentiation. The ECM not only provides mechanical support but also plays a crucial role in cell signaling, influencing processes like wound healing, embryonic development, and tissue remodeling. The composition and properties of the ECM can vary significantly between different tissues, reflecting their specific functional requirements.
North American market for Extracellular Matrix (ECM) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Extracellular Matrix (ECM) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Extracellular Matrix (ECM) was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Extracellular Matrix (ECM) include Merck, Smith&Nephew, DSM Biomedical, Corning, Thermo Fisher, AMSBIO, Mimetas, FUJIFILM, CellSystems, Advanced BioMatrix, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Extracellular Matrix (ECM), focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Extracellular Matrix (ECM) by region & country, by Type, and by Application.
The Extracellular Matrix (ECM) market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Extracellular Matrix (ECM).
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Extracellular Matrix (ECM) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Extracellular Matrix (ECM) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Extracellular Matrix (ECM) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Extracellular Matrix (ECM) Product Introduction
1.2 Global Extracellular Matrix (ECM) Market Size Forecast (2020-2031)
1.3 Extracellular Matrix (ECM) Market Trends & Drivers
1.3.1 Extracellular Matrix (ECM) Industry Trends
1.3.2 Extracellular Matrix (ECM) Market Drivers & Opportunity
1.3.3 Extracellular Matrix (ECM) Market Challenges
1.3.4 Extracellular Matrix (ECM) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Extracellular Matrix (ECM) Players Revenue Ranking (2024)
2.2 Global Extracellular Matrix (ECM) Revenue by Company (2020-2025)
2.3 Key Companies Extracellular Matrix (ECM) Manufacturing Base Distribution and Headquarters
2.4 Key Companies Extracellular Matrix (ECM) Product Offered
2.5 Key Companies Time to Begin Mass Production of Extracellular Matrix (ECM)
2.6 Extracellular Matrix (ECM) Market Competitive Analysis
2.6.1 Extracellular Matrix (ECM) Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Extracellular Matrix (ECM) Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Extracellular Matrix (ECM) as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Animal-derived EMC
3.1.2 Human-derived EMC
3.1.3 Synthetic EMC
3.2 Global Extracellular Matrix (ECM) Sales Value by Type
3.2.1 Global Extracellular Matrix (ECM) Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Extracellular Matrix (ECM) Sales Value, by Type (2020-2031)
3.2.3 Global Extracellular Matrix (ECM) Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Biopharmaceuticals
4.1.2 Clinical Medicine
4.1.3 Academic Research
4.1.4 Others
4.2 Global Extracellular Matrix (ECM) Sales Value by Application
4.2.1 Global Extracellular Matrix (ECM) Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Extracellular Matrix (ECM) Sales Value, by Application (2020-2031)
4.2.3 Global Extracellular Matrix (ECM) Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Extracellular Matrix (ECM) Sales Value by Region
5.1.1 Global Extracellular Matrix (ECM) Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Extracellular Matrix (ECM) Sales Value by Region (2020-2025)
5.1.3 Global Extracellular Matrix (ECM) Sales Value by Region (2026-2031)
5.1.4 Global Extracellular Matrix (ECM) Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Extracellular Matrix (ECM) Sales Value, 2020-2031
5.2.2 North America Extracellular Matrix (ECM) Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Extracellular Matrix (ECM) Sales Value, 2020-2031
5.3.2 Europe Extracellular Matrix (ECM) Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Extracellular Matrix (ECM) Sales Value, 2020-2031
5.4.2 Asia Pacific Extracellular Matrix (ECM) Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Extracellular Matrix (ECM) Sales Value, 2020-2031
5.5.2 South America Extracellular Matrix (ECM) Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Extracellular Matrix (ECM) Sales Value, 2020-2031
5.6.2 Middle East & Africa Extracellular Matrix (ECM) Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Extracellular Matrix (ECM) Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Extracellular Matrix (ECM) Sales Value, 2020-2031
6.3 United States
6.3.1 United States Extracellular Matrix (ECM) Sales Value, 2020-2031
6.3.2 United States Extracellular Matrix (ECM) Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Extracellular Matrix (ECM) Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Extracellular Matrix (ECM) Sales Value, 2020-2031
6.4.2 Europe Extracellular Matrix (ECM) Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Extracellular Matrix (ECM) Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Extracellular Matrix (ECM) Sales Value, 2020-2031
6.5.2 China Extracellular Matrix (ECM) Sales Value by Type (%), 2024 VS 2031
6.5.3 China Extracellular Matrix (ECM) Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Extracellular Matrix (ECM) Sales Value, 2020-2031
6.6.2 Japan Extracellular Matrix (ECM) Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Extracellular Matrix (ECM) Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Extracellular Matrix (ECM) Sales Value, 2020-2031
6.7.2 South Korea Extracellular Matrix (ECM) Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Extracellular Matrix (ECM) Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Extracellular Matrix (ECM) Sales Value, 2020-2031
6.8.2 Southeast Asia Extracellular Matrix (ECM) Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Extracellular Matrix (ECM) Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Extracellular Matrix (ECM) Sales Value, 2020-2031
6.9.2 India Extracellular Matrix (ECM) Sales Value by Type (%), 2024 VS 2031
6.9.3 India Extracellular Matrix (ECM) Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Merck
7.1.1 Merck Profile
7.1.2 Merck Main Business
7.1.3 Merck Extracellular Matrix (ECM) Products, Services and Solutions
7.1.4 Merck Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.1.5 Merck Recent Developments
7.2 Smith&Nephew
7.2.1 Smith&Nephew Profile
7.2.2 Smith&Nephew Main Business
7.2.3 Smith&Nephew Extracellular Matrix (ECM) Products, Services and Solutions
7.2.4 Smith&Nephew Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.2.5 Smith&Nephew Recent Developments
7.3 DSM Biomedical
7.3.1 DSM Biomedical Profile
7.3.2 DSM Biomedical Main Business
7.3.3 DSM Biomedical Extracellular Matrix (ECM) Products, Services and Solutions
7.3.4 DSM Biomedical Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.3.5 DSM Biomedical Recent Developments
7.4 Corning
7.4.1 Corning Profile
7.4.2 Corning Main Business
7.4.3 Corning Extracellular Matrix (ECM) Products, Services and Solutions
7.4.4 Corning Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.4.5 Corning Recent Developments
7.5 Thermo Fisher
7.5.1 Thermo Fisher Profile
7.5.2 Thermo Fisher Main Business
7.5.3 Thermo Fisher Extracellular Matrix (ECM) Products, Services and Solutions
7.5.4 Thermo Fisher Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.5.5 Thermo Fisher Recent Developments
7.6 AMSBIO
7.6.1 AMSBIO Profile
7.6.2 AMSBIO Main Business
7.6.3 AMSBIO Extracellular Matrix (ECM) Products, Services and Solutions
7.6.4 AMSBIO Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.6.5 AMSBIO Recent Developments
7.7 Mimetas
7.7.1 Mimetas Profile
7.7.2 Mimetas Main Business
7.7.3 Mimetas Extracellular Matrix (ECM) Products, Services and Solutions
7.7.4 Mimetas Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.7.5 Mimetas Recent Developments
7.8 FUJIFILM
7.8.1 FUJIFILM Profile
7.8.2 FUJIFILM Main Business
7.8.3 FUJIFILM Extracellular Matrix (ECM) Products, Services and Solutions
7.8.4 FUJIFILM Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.8.5 FUJIFILM Recent Developments
7.9 CellSystems
7.9.1 CellSystems Profile
7.9.2 CellSystems Main Business
7.9.3 CellSystems Extracellular Matrix (ECM) Products, Services and Solutions
7.9.4 CellSystems Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.9.5 CellSystems Recent Developments
7.10 Advanced BioMatrix
7.10.1 Advanced BioMatrix Profile
7.10.2 Advanced BioMatrix Main Business
7.10.3 Advanced BioMatrix Extracellular Matrix (ECM) Products, Services and Solutions
7.10.4 Advanced BioMatrix Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.10.5 Advanced BioMatrix Recent Developments
7.11 Bio-Techne
7.11.1 Bio-Techne Profile
7.11.2 Bio-Techne Main Business
7.11.3 Bio-Techne Extracellular Matrix (ECM) Products, Services and Solutions
7.11.4 Bio-Techne Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.11.5 Bio-Techne Recent Developments
7.12 AROA Biosurgery
7.12.1 AROA Biosurgery Profile
7.12.2 AROA Biosurgery Main Business
7.12.3 AROA Biosurgery Extracellular Matrix (ECM) Products, Services and Solutions
7.12.4 AROA Biosurgery Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.12.5 AROA Biosurgery Recent Developments
7.13 Integra LifeSciences
7.13.1 Integra LifeSciences Profile
7.13.2 Integra LifeSciences Main Business
7.13.3 Integra LifeSciences Extracellular Matrix (ECM) Products, Services and Solutions
7.13.4 Integra LifeSciences Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.13.5 Integra LifeSciences Recent Developments
7.14 Elutia
7.14.1 Elutia Profile
7.14.2 Elutia Main Business
7.14.3 Elutia Extracellular Matrix (ECM) Products, Services and Solutions
7.14.4 Elutia Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.14.5 Elutia Recent Developments
7.15 ReproCELL
7.15.1 ReproCELL Profile
7.15.2 ReproCELL Main Business
7.15.3 ReproCELL Extracellular Matrix (ECM) Products, Services and Solutions
7.15.4 ReproCELL Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.15.5 ReproCELL Recent Developments
7.16 Biolamina
7.16.1 Biolamina Profile
7.16.2 Biolamina Main Business
7.16.3 Biolamina Extracellular Matrix (ECM) Products, Services and Solutions
7.16.4 Biolamina Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.16.5 Biolamina Recent Developments
7.17 Tissue Regenix
7.17.1 Tissue Regenix Profile
7.17.2 Tissue Regenix Main Business
7.17.3 Tissue Regenix Extracellular Matrix (ECM) Products, Services and Solutions
7.17.4 Tissue Regenix Extracellular Matrix (ECM) Revenue (US$ Million) & (2020-2025)
7.17.5 Tissue Regenix Recent Developments
8 Industry Chain Analysis
8.1 Extracellular Matrix (ECM) Industrial Chain
8.2 Extracellular Matrix (ECM) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Extracellular Matrix (ECM) Sales Model
8.5.2 Sales Channel
8.5.3 Extracellular Matrix (ECM) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Extracellular Matrix (ECM) market is projected to grow from US$ 42.34 million in 2025 to US$ 70.66 million by 2032, at a CAGR of 7.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 148
USD 4900.00
(Single User License)
The global Extracellular Matrix (ECM) market size was US$ 42.34 million in 2025 and is forecast to reach a readjusted size of US$ 70.66 million by 2032 with a CAGR of 7.7% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 103
USD 4250.00
(Single User License)
The global Extracellular Matrix (ECM) market was valued at US$ 42.34 million in 2025 and is anticipated to reach US$ 70.66 million by 2032, at a CAGR of 7.7% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 132
USD 2900.00
(Single User License)
The global market for Extracellular Matrix (ECM) was estimated to be worth US$ 42.34 million in 2025 and is projected to reach US$ 70.66 million, growing at a CAGR of 7.7% from 2026 to 2032.
Published Date: 2026-01-09
Pages: 124
USD 3950.00
(Single User License)
The global Extracellular Matrix (ECM) market is projected to grow from US$ 39.6 million in 2024 to US$ 66.1 million by 2031, at a CAGR of 7.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 160
USD 4900.00
(Single User License)
The global Extracellular Matrix (ECM) market size was US$ 39.6 million in 2024 and is forecast to a readjusted size of US$ 66.1 million by 2031 with a CAGR of 7.7% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 109
USD 4250.00
(Single User License)
The global market for Extracellular Matrix (ECM) was valued at US$ 39.6 million in the year 2024 and is projected to reach a revised size of US$ 66.1 million by 2031, growing at a CAGR of 7.7% during the forecast period.
Published Date: 2025-03-10
Pages: 96
USD 2900.00
(Single User License)
The extracellular matrix (ECM) is a complex network of proteins and carbohydrates that provides structural and biochemical support to the surrounding cells in tissues. It is composed of various molecules, including collagen, elastin, glycoproteins, and proteoglycans, which create a scaffold that maintains tissue integrity and regulates cellular behaviors such as adhesion, migration, proliferation, and differentiation. The ECM not only provides mechanical support but also plays a crucial role in cell signaling, influencing processes like wound healing, embryonic development, and tissue remodeling. The composition and properties of the ECM can vary significantly between different tissues, reflecting their specific functional requirements.
Published Date: 2024-08-16
Pages: 121
USD 4350.00
(Single User License)
The extracellular matrix (ECM) is a complex network of proteins and carbohydrates that provides structural and biochemical support to the surrounding cells in tissues. It is composed of various molecules, including collagen, elastin, glycoproteins, and proteoglycans, which create a scaffold that maintains tissue integrity and regulates cellular behaviors such as adhesion, migration, proliferation, and differentiation. The ECM not only provides mechanical support but also plays a crucial role in cell signaling, influencing processes like wound healing, embryonic development, and tissue remodeling. The composition and properties of the ECM can vary significantly between different tissues, reflecting their specific functional requirements.
Published Date: 2024-08-16
Pages: 99
USD 2900.00
(Single User License)
The extracellular matrix (ECM) is a complex network of proteins and carbohydrates that provides structural and biochemical support to the surrounding cells in tissues. It is composed of various molecules, including collagen, elastin, glycoproteins, and proteoglycans, which create a scaffold that maintains tissue integrity and regulates cellular behaviors such as adhesion, migration, proliferation, and differentiation. The ECM not only provides mechanical support but also plays a crucial role in cell signaling, influencing processes like wound healing, embryonic development, and tissue remodeling. The composition and properties of the ECM can vary significantly between different tissues, reflecting their specific functional requirements.
Published Date: 2024-08-16
Pages: 158
USD 4900.00
(Single User License)
The global Extracellular Matrix (ECM) market is projected to grow from US$ 42.34 million in 2025 to US$ 70.66 million by 2032, at a CAGR of 7.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 148
The global Extracellular Matrix (ECM) market size was US$ 42.34 million in 2025 and is forecast to reach a readjusted size of US$ 70.66 million by 2032 with a CAGR of 7.7% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 103
The global Extracellular Matrix (ECM) market was valued at US$ 42.34 million in 2025 and is anticipated to reach US$ 70.66 million by 2032, at a CAGR of 7.7% from 2026 to 2032.
Published: 2026-01-09
Pages: 132
The global market for Extracellular Matrix (ECM) was estimated to be worth US$ 42.34 million in 2025 and is projected to reach US$ 70.66 million, growing at a CAGR of 7.7% from 2026 to 2032.
Published: 2026-01-09
Pages: 124
The global Extracellular Matrix (ECM) market is projected to grow from US$ 39.6 million in 2024 to US$ 66.1 million by 2031, at a CAGR of 7.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 160
The global Extracellular Matrix (ECM) market size was US$ 39.6 million in 2024 and is forecast to a readjusted size of US$ 66.1 million by 2031 with a CAGR of 7.7% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 109
The global market for Extracellular Matrix (ECM) was valued at US$ 39.6 million in the year 2024 and is projected to reach a revised size of US$ 66.1 million by 2031, growing at a CAGR of 7.7% during the forecast period.
Published: 2025-03-10
Pages: 96
The extracellular matrix (ECM) is a complex network of proteins and carbohydrates that provides structural and biochemical support to the surrounding cells in tissues. It is composed of various molecules, including collagen, elastin, glycoproteins, and proteoglycans, which create a scaffold that maintains tissue integrity and regulates cellular behaviors such as adhesion, migration, proliferation, and differentiation. The ECM not only provides mechanical support but also plays a crucial role in cell signaling, influencing processes like wound healing, embryonic development, and tissue remodeling. The composition and properties of the ECM can vary significantly between different tissues, reflecting their specific functional requirements.
Published: 2024-08-16
Pages: 121
The extracellular matrix (ECM) is a complex network of proteins and carbohydrates that provides structural and biochemical support to the surrounding cells in tissues. It is composed of various molecules, including collagen, elastin, glycoproteins, and proteoglycans, which create a scaffold that maintains tissue integrity and regulates cellular behaviors such as adhesion, migration, proliferation, and differentiation. The ECM not only provides mechanical support but also plays a crucial role in cell signaling, influencing processes like wound healing, embryonic development, and tissue remodeling. The composition and properties of the ECM can vary significantly between different tissues, reflecting their specific functional requirements.
Published: 2024-08-16
Pages: 99
The extracellular matrix (ECM) is a complex network of proteins and carbohydrates that provides structural and biochemical support to the surrounding cells in tissues. It is composed of various molecules, including collagen, elastin, glycoproteins, and proteoglycans, which create a scaffold that maintains tissue integrity and regulates cellular behaviors such as adhesion, migration, proliferation, and differentiation. The ECM not only provides mechanical support but also plays a crucial role in cell signaling, influencing processes like wound healing, embryonic development, and tissue remodeling. The composition and properties of the ECM can vary significantly between different tissues, reflecting their specific functional requirements.
Published: 2024-08-16
Pages: 158
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now